Chronic exposure to the TGF‐β promotes a stable EMT state in mammary carcinoma cells accompanied by stable generation of cancer stem cells (CSCs) and drug resistance that cannot be reversed after withdrawal of TGF‐β, but it is responsive to the mTOR inhibition.66 The gene discussed is TGFB1; the disease is cancer.